| Role |
Name |
Disclosure |
Details |
| Author | Brian S Carter, MD, FAAP, Professor of Pediatrics, Department of Pediatrics, Division of Neonatology, Vanderbilt University School of Medicine; Co-director, Pediatric Advance Comfort Team, Vanderbilt Children's Hospital | Nothing to disclose | Details | | Medical Editor | Scott S MacGilvray, MD, Associate Professor, Department of Pediatrics, East Carolina University School of Medicine | MedImmune Speakers Bureau | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | Managing Editor | Brian S Carter, MD, FAAP, Professor of Pediatrics, Department of Pediatrics, Division of Neonatology, Vanderbilt University School of Medicine; Co-director, Pediatric Advance Comfort Team, Vanderbilt Children's Hospital | Nothing to disclose | Details | | CME Editor | Carol L Wagner, MD, Professor of Pediatrics, Medical University of South Carolina | Nothing to disclose | Details | | Chief Editor | Neil N Finer, MD, Professor, Department of Pediatrics, University of California at San Diego School of Medicine; Program Director, Division of Neonatology, University of California San Diego Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Carol L Wagner, CME Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Neil N Finer, Chief Editor |
The contributor discloses no conflict of interest. |
|